Table 3.

Correlation of Raman bands of erythrocyte hemoglobin hematoporphyrin of apparently healthy people and people with SA and MI before and after treatment, n = 20 (М  ± SD).

Test groups	Indices
	Percentage of oxyhemoglobin blood I1375/(I1355 + I1375)	Relative ability of hemoglobin to bind ligands I1355/I1550	Relative ability of hemoglobin to drop off ligands I1375/I1580	Hemoglobin ligand affinity (О2) (I1355/I1550)/(I1375/I1580)
Control	0.69 ± 0.03	0.61 ± 0.03	0.53 ± 0.02	1.16 ± 0.07
SA patients before treatment	0.54 ± 0.02∗	0.70 ± 0.03∗	0.44 ± 0.03∗	1.56 ± 0.12∗
SA patients after treatment	0.61 ± 0.03∗	0.67 ± 0.04∗	0.48 ± 0.03	1.41 ± 0.15∗
MI patients before treatment	0.52 ± 0.03∗	0.76 ± 0.03∗	0.40 ± 0.02∗	1.90 ± 0.11∗
MI patients after treatment	0.58 ± 0.04∗	0.75 ± 0.05∗	0.42 ± 0.03∗	1.52 ± 0.10∗Δ

^∗ p < 0.05, reliability in relation to donors' indicators; ^Δp < 0.05, reliability in relation to pretreatment indicators.